Provides revenue cycle management (RCM) solutions for healthcare providers. Offers electronic health record (EHR) systems for community hospitals and clinics. Now — the numbers.
This is an established company with proven profits.
Average growth of 5% a year over the last 4 years. Red columns mark years that ended in a loss.
The gap is $141.9M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 90.4× for every dollar this company earns in a year — a price that already assumes things go well.
Against companies in its own sector, it looks cheaper than 73% of them.
Analysts' average target sits 0% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
This grade is a blend: the profit side is strong, the sales tempo slow.
Clearly above the class average — a step short of the very top.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
The stock trades 30% below its peak. The market has trimmed its expectations for the company.
Our checks did not surface a specific strength to highlight here.
The company’s market value is 90 times its annual profit. Even a small disappointment could hit the price hard.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 21/100.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.